-TheWire.in The government’s premier policy-formulating agency recently recommended measures to deregulate the pharmaceutical sector and make essential medicines more expensive. New Delhi: Even as the prime minister repeatedly expresses his commitment to providing affordable medicines in the country, it appears that the NITI Aayog and the Department of Pharmaceuticals (DoP) may be working in an opposing direction. Documents between October 2016 and April 2017 show the intention of various government arms to...

-Frontline.in The British government, on the basis of an 1891 report on the subhuman living conditions of “Pariahs” by James H.A. Tremenheere, Acting Collector of Chengleput, assigned 12 lakh acres of land for distribution to the “depressed classes” of the Madras Presidency to empower them socially and economically. But more than 100 years later, much of this land is in the possession of non-Dalits, and the struggle to reclaim them has...

-Scroll.in India’s first chief statistician, Pronab Sen, is now country director of the International Growth Centre, which seeks to build effective growth facilities through engagement between policymakers and researchers. In this interview to Scroll.in, he speaks on the 50 days of demonetisation, its failings, its severe impact on the poor, the loss of credibility of the Reserve Bank of India, the push to make India a cashless or less-cash economy, and...

-Business Standard The demonetisation drive has hit job creation, beside adding to the stress on banks New Delhi: Demonetisation is expected to negatively impact the overall economy and job generation, a number of economists told Parliament's standing committee on finance. Reserve Bank governor Urjit Patel was to come but could not; he will do so on January 18.   The panel heard four economists — former chief statistician Pronab Sen; Mahesh Vyas, head of...

-The Economic Times NEW DELHI: Civil society group All India Drug Action Network (AIDAN) has sent legal notices to Niti Aayog CEO and secretaries to the health ministry, department of pharmaceuticals and Department of Industrial Policy and promotion over their talks to cut powers of the National Pharmaceutical Pricing Authority. The group has termed the move “anti-national” and “anti-people”, adding that it affects an ongoing case at the Supreme Court over various...